Neumora Therapeutics (NMRA)'s 30-day implied volatility (IV30) was 134.3% at the close on November 5, 2026, up from 130.5% the day before, against a 52-week range of 59.6% to 277.8%. Its 20-day historical volatility was 164.8%.
Data as of November 5, 2026.